Jianzhijia Pharmaceutical Chain Group Co., Ltd.

XSSC:605266 Stock Report

Market Cap: CN¥4.1b

Jianzhijia Pharmaceutical Chain Group Future Growth

Future criteria checks 5/6

Jianzhijia Pharmaceutical Chain Group is forecast to grow earnings and revenue by 35.8% and 22.1% per annum respectively. EPS is expected to grow by 34.7% per annum. Return on equity is forecast to be 17% in 3 years.

Key information

35.8%

Earnings growth rate

34.7%

EPS growth rate

Consumer Retailing earnings growth41.6%
Revenue growth rate22.1%
Future return on equity17.0%
Analyst coverage

Low

Last updated26 Jun 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:605266 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202615,719685N/A1,2521
12/31/202513,057562N/A1,1901
12/31/202410,768469N/A1,1501
9/30/20249,316237535818N/A
6/30/20249,228319452764N/A
3/31/20249,228390468793N/A
12/31/20239,0814147241,024N/A
9/30/20239,3054577991,078N/A
6/30/20238,8464421,1851,408N/A
3/31/20238,2314191,3541,551N/A
12/31/20227,5143744101,191N/A
9/30/20226,277300631,018N/A
6/30/20225,862268-177780N/A
3/31/20225,518267-280691N/A
12/31/20215,235301359744N/A
9/30/20214,947276506724N/A
6/30/20214,737262329536N/A
3/31/20214,578262179339N/A
12/31/20204,466251184317N/A
9/30/20204,213215186315N/A
12/31/20193,529168204338N/A
12/31/20182,76613489193N/A
12/31/20172,34795N/A206N/A
12/31/20162,05471N/A145N/A
12/31/20151,84418N/A-16N/A
12/31/20141,66717N/A66N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 605266's forecast earnings growth (35.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 605266's earnings (35.8% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 605266's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 605266's revenue (22.1% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 605266's revenue (22.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 605266's Return on Equity is forecast to be low in 3 years time (17%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y